Dermata Therapeutics Warrant Stock Buy Hold or Sell Recommendation
| DRMAW Stock | USD 0.02 0.01 96.08% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Dermata Therapeutics Warrant is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Dermata Therapeutics Warrant given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Dermata Therapeutics Warrant, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Dermata Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Dermata Stock please use our How to Invest in Dermata Therapeutics guide. Note, we conduct extensive research on individual companies such as Dermata and provide practical buy, sell, or hold advice based on investors' constraints. Dermata Therapeutics Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Dermata |
Execute Dermata Therapeutics Buy or Sell Advice
The Dermata recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Dermata Therapeutics Warrant. Macroaxis does not own or have any residual interests in Dermata Therapeutics Warrant or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Dermata Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Dermata Therapeutics Trading Alerts and Improvement Suggestions
| Dermata Therapeutics is way too risky over 90 days horizon | |
| Dermata Therapeutics has some characteristics of a very speculative penny stock | |
| Dermata Therapeutics appears to be risky and price may revert if volatility continues | |
| Dermata Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.79 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Dermata Therapeutics generates negative cash flow from operations | |
| Dermata Therapeutics has a frail financial position based on the latest SEC disclosures |
Dermata Therapeutics Returns Distribution Density
The distribution of Dermata Therapeutics' historical returns is an attempt to chart the uncertainty of Dermata Therapeutics' future price movements. The chart of the probability distribution of Dermata Therapeutics daily returns describes the distribution of returns around its average expected value. We use Dermata Therapeutics Warrant price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Dermata Therapeutics returns is essential to provide solid investment advice for Dermata Therapeutics.
| Mean Return | 3.30 | Value At Risk | -27.01 | Potential Upside | 40.94 | Standard Deviation | 22.21 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Dermata Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Dermata Therapeutics Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (1.5M) | 10.3M | (4.6M) | 1.2M | 1.1M | 1.0M | |
| Stock Based Compensation | 0.0 | 1.9M | 930.3K | 522.1K | 600.4K | 738.9K | |
| Free Cash Flow | (4.0M) | (5.7M) | (8.8M) | (6.4M) | (5.8M) | (6.1M) | |
| Change In Working Capital | (755.8K) | 289.6K | (153.6K) | 863.7K | 993.2K | 1.0M | |
| Begin Period Cash Flow | 2.0M | 530.4K | 10.8M | 6.2M | 7.2M | 4.6M | |
| Other Cashflows From Financing Activities | 3.2M | (430K) | 287.0 | 187.0 | 168.3 | 159.89 | |
| Other Non Cash Items | (36.5K) | 14.1K | 930.3K | 522.1K | 600.4K | 506.6K | |
| Total Cash From Operating Activities | (4.0M) | (5.7M) | (8.8M) | (6.4M) | (5.8M) | (6.1M) | |
| Issuance Of Capital Stock | 268.8K | 16.0M | 4.3M | 5.7M | 6.5M | 6.9M | |
| Net Income | (3.2M) | (7.9M) | (9.6M) | (7.8M) | (7.0M) | (7.4M) | |
| Total Cash From Financing Activities | 2.6M | 16.0M | 4.3M | 7.6M | 8.7M | 7.7M | |
| End Period Cash Flow | 530.4K | 10.8M | 6.2M | 7.4M | 8.6M | 5.9M |
Dermata Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dermata Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dermata Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Dermata stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 2.93 | |
β | Beta against Dow Jones | -3.25 | |
σ | Overall volatility | 23.40 | |
Ir | Information ratio | 0.15 |
Dermata Therapeutics Volatility Alert
Dermata Therapeutics Warrant is showing large volatility of returns over the selected time horizon. Dermata Therapeutics Warrant is a penny stock. Although Dermata Therapeutics may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Dermata Therapeutics Warrant. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Dermata instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Dermata Therapeutics Fundamentals Vs Peers
Comparing Dermata Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Dermata Therapeutics' direct or indirect competition across all of the common fundamentals between Dermata Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Dermata Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Dermata Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Dermata Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Dermata Therapeutics to competition |
| Fundamentals | Dermata Therapeutics | Peer Average |
| Return On Equity | -2.02 | -0.31 |
| Return On Asset | -1.03 | -0.14 |
| Number Of Shares Shorted | 28.04 K | 4.71 M |
| EBITDA | 247.22 K | 3.9 B |
| Net Income | (7.79 M) | 570.98 M |
| Total Debt | 1.62 M | 5.32 B |
| Book Value Per Share | 2.83 X | 1.93 K |
| Cash Flow From Operations | (6.41 M) | 971.22 M |
| Earnings Per Share | (2.16) X | 3.12 X |
| Number Of Employees | 8 | 18.84 K |
| Beta | 0.65 | -0.15 |
| Total Asset | 7.98 M | 29.47 B |
| Retained Earnings | (53.39 M) | 9.33 B |
| Working Capital | 6.36 M | 1.48 B |
| Net Asset | 7.98 M |
Note: Acquisition by David Hale of 10000 shares of Dermata Therapeutics at 0.6099 subject to Rule 16b-3 [view details]
Dermata Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Dermata . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.015 | |||
| Daily Balance Of Power | 32.666667 | |||
| Rate Of Daily Change | 1.96 | |||
| Day Median Price | 0.0199 | |||
| Day Typical Price | 0.0199 | |||
| Market Facilitation Index | 3.0E-4 | |||
| Price Action Indicator | 0.0051 | |||
| Period Momentum Indicator | 0.0098 |
About Dermata Therapeutics Buy or Sell Advice
When is the right time to buy or sell Dermata Therapeutics Warrant? Buying financial instruments such as Dermata Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Dermata Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Disruptive Technologies Thematic Idea Now
Disruptive Technologies
New or established technology companies and funds across multiple sectors that are involved in development or marketing of products or services that experience disruptive trends and that are at the forefront of discussions on Wall Street. The Disruptive Technologies theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Disruptive Technologies Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.